Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316666 | SCV000666813 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2017-02-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001503156 | SCV001708005 | likely benign | Neurofibromatosis, type 1 | 2023-11-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001503156 | SCV002560607 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230547 | SCV003928900 | likely benign | not specified | 2023-04-27 | criteria provided, single submitter | clinical testing |